LIMES Schlosskliniken Past Earnings Performance

Past criteria checks 2/6

LIMES Schlosskliniken has been growing earnings at an average annual rate of 70.7%, while the Healthcare industry saw earnings growing at 4.4% annually. Revenues have been growing at an average rate of 39.3% per year. LIMES Schlosskliniken's return on equity is 31.6%, and it has net margins of 11%.

Key information

70.7%

Earnings growth rate

70.9%

EPS growth rate

Healthcare Industry Growth15.7%
Revenue growth rate39.3%
Return on equity31.6%
Net Margin11.0%
Last Earnings Update30 Jun 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How LIMES Schlosskliniken makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:LIK Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2330350
31 Mar 2329440
31 Dec 2229440
30 Sep 2229440
30 Jun 2229440
31 Mar 2226440
31 Dec 2123440
30 Sep 2119330
30 Jun 2115230
31 Mar 2113030
31 Dec 2011-120
30 Sep 2010-110
30 Jun 209-100
31 Mar 209-100
31 Dec 198-100
30 Sep 198-100
30 Jun 198-110
31 Mar 198-110
31 Dec 188-110
31 Dec 177-120

Quality Earnings: LIK has a high level of non-cash earnings.

Growing Profit Margin: LIK's current net profit margins (11%) are lower than last year (15.1%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: LIK has become profitable over the past 5 years, growing earnings by 70.7% per year.

Accelerating Growth: LIK's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: LIK had negative earnings growth (-24.6%) over the past year, making it difficult to compare to the Healthcare industry average (-7.5%).


Return on Equity

High ROE: LIK's Return on Equity (31.6%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.